Statements (30)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:naproxen
esomeprazole |
| gptkbp:approvalYear |
2010
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
M01AE52
|
| gptkbp:contraindication |
active gastrointestinal bleeding
hypersensitivity to esomeprazole hypersensitivity to naproxen |
| gptkbp:drugClass |
proton pump inhibitor
nonsteroidal anti-inflammatory drug |
| gptkbp:form |
delayed-release tablet
|
| https://www.w3.org/2000/01/rdf-schema#label |
Vimovo
|
| gptkbp:legalStatus |
Rx-only
|
| gptkbp:manufacturer |
gptkb:AstraZeneca
gptkb:Horizon_Pharma |
| gptkbp:pregnancyCategory |
C/D (US)
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:reduces |
NSAID-associated gastric ulcers
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
diarrhea headache dyspepsia |
| gptkbp:usedFor |
osteoarthritis
pain relief rheumatoid arthritis ankylosing spondylitis |
| gptkbp:bfsParent |
gptkb:Bausch_Health_Companies_Inc.
|
| gptkbp:bfsLayer |
7
|